Working… Menu
Trial record 49 of 2100 for:    cancer vaccine

Derivation of Tumor Specific Hybridomas

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01702792
Recruitment Status : Terminated (Investigator is leaving Dartmouth)
First Posted : October 8, 2012
Last Update Posted : April 4, 2018
University of Vermont
Information provided by (Responsible Party):
Dartmouth-Hitchcock Medical Center

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : May 6, 2015
Actual Study Completion Date : May 6, 2015